Kazan Organichesky sintez (MCX:KZOS) earnings growth rate below 21% CAGR provided to shareholders
Not the best quarter since Kazan Public Joint Stock Company Organichesky sintez (MCX:KZOS) shareholders, as the stock price fell 18% during this period. But at least the stock is up over the past five years. However, we are not very impressed as the stock price only rose 87%, less than the market return of 91%.
Although Kazan Organichesky sintez lost €17 billion of its market capitalization this week, let’s take a look at its longer-term fundamental trends and see if they have generated any returns.
Check out our latest analysis for Kazan Organichesky sintez
It is undeniable that markets are sometimes efficient, but prices do not always reflect the underlying performance of companies. An imperfect but reasonable way to gauge changing sentiment around a company is to compare earnings per share (EPS) with the stock price.
Over five years of share price growth, Kazan Organichesky sintez has achieved compound earnings per share (EPS) growth of 0.4% per year. This EPS growth is less than the average annual share price increase of 13%. It is therefore fair to assume that the market has a better opinion of the company than five years ago. And that’s hardly shocking given the track record of growth.
The company’s earnings per share (over time) is shown in the image below (click to see exact numbers).
Dive deeper into Kazan Organichesky sintez’s key metrics by viewing this interactive graph of Kazan Organichesky sintez earnings, revenue and cash flow.
What about dividends?
In addition to measuring share price performance, investors should also consider total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital increases, as well as any dividends, on the basis of the assumption that dividends are reinvested. It’s fair to say that the TSR gives a more complete picture of stocks that pay a dividend. It turns out that the TSR of Kazan Organichesky sintez for the past 5 years was 163%, which exceeds the stock price return mentioned earlier. The dividends paid by the company thus inflated the total return to shareholders.
A different perspective
Kazan Organichesky sintez shareholders earned a total return of 5.9% during the year. But this yield is lower than the market. It’s probably a good sign that the company has an even better long-term balance sheet, having provided shareholders with an annual TSR of 21% over five years. It is entirely possible that the company will continue to operate with prowess, even if the stock price gains slow. It is always interesting to follow the evolution of the share price over the long term. But to better understand Kazan Organichesky sintez, we need to consider many other factors. To do this, you need to find out about the 3 warning signs we spotted some with Kazan Organichesky sintez (including 1 which is potentially serious).
Sure, you might find a fantastic investment by looking elsewhere. So take a look at this free list of companies that we believe will increase their profits.
Please note that the market returns quoted in this article reflect the average market-weighted returns of the shares currently trading on UK stock exchanges.
Feedback on this article? Concerned about content? Get in touch with us directly. You can also email the editorial team (at) Simplywallst.com.
This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts only using unbiased methodology and our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. Our goal is to bring you targeted long-term analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price-sensitive companies or qualitative materials. Simply Wall St has no position in the stocks mentioned.